Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Malignant Neoplasms of Female Genital Organs 1

Interventions

Selenium 4Epoetin Alfa 3Vitamin E 2Darbepoetin alfa 2Aminolevulinic Acid 2venetoclax 1tirbanibulin 1human papillomavirus vaccine, L1 type 16, 18 1fludarabine 1ferrous sulfate 1ferric gluconate 1camrelizumab 1alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Toremifene 1Surveys and Questionnaires 1Sulindac 1Sucrose 1Soybean Proteins 1Rosuvastatin Calcium 1Ropivacaine 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Propofol 1Polymerase Chain Reaction 1Oxycodone 1Ondansetron 1Morphine 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Oxycodone × Other neoplasm × Clear all
NCT02740114 2021-10-18

Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway

M.D. Anderson Cancer Center

Phase 3 Terminated
105 enrolled 9 charts
GynecologicOther neoplasm

Malignant Neoplasms of Female Genital Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡